Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutati
ClinicalTrials.gov study NCT01357161. IPD Sharing: YES. Countries: 0. Publications: 0.
DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT03657966. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
ClinicalTrials.gov study NCT03220932. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT00243204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT07042802. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01494012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT06292286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
ClinicalTrials.gov study NCT01040312. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
ClinicalTrials.gov study NCT06686030. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC
ClinicalTrials.gov study NCT06977828. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04519151. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05407155. IPD Sharing: NO. Countries: 0. Publications: 0.
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
ClinicalTrials.gov study NCT03924245. IPD Sharing: NO. Countries: 1. Publications: 0.
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
ClinicalTrials.gov study NCT07131319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT04511481. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03480230. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05617755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
ClinicalTrials.gov study NCT06123884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC
ClinicalTrials.gov study NCT04840290. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
ClinicalTrials.gov study NCT03763123. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.